title: [Characteristics of the treatment of ischemic heart disease with delayed-action verapamil].
abstract: Pre- and posttreatment indices of platelet and plasma hemostasis, parameters of long-term ECG-ST monitoring were measured in 30 coronary patients on long-term verapamil regimens. ++Anti-ischemic effect of the drug was dependent on clinical pattern of the disease and initial function of the platelets. Plasma hemostasis was found unaffected. Long-term verapamil treatment is indicated in stable angina pectoris class II and III provided platelets demonstrate enhanced functional activity.
authors.forename: E I
authors.initials: EI
authors.lastname: Zharov
authors.forename: T K
authors.initials: TK
authors.lastname: Styrova
authors.forename: V G
authors.initials: VG
authors.lastname: Barinov
authors.forename: A I
authors.initials: AI
authors.lastname: Martynov
authors.forename: I V
authors.initials: IV
authors.lastname: Galichenko
authors.forename: V P
authors.initials: VP
authors.lastname: Sedov
authors.forename: A L
authors.initials: AL
authors.lastname: Vertkin
mesh_terms: D000328:Adult; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D006403:Hematologic Tests; D006487:Hemostasis / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects / Q000502:physiology; D010975:Platelet Aggregation Inhibitors; D014700:Verapamil / Q000008:administration & dosage*
chemical_list: D003692:Delayed-Action Preparations; D010975:Platelet Aggregation Inhibitors; D014700:Verapamil
vernacular_title: Osobennosti lecheniia bol'nykh ishemicheskoĭ bolezn'iu serdtsa prolongirovannym verapamilom.